Amikacin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Aminoglycoside antibiotic.

Half-lifeThis section has been translated automatically.

1,8–3 h

Spectrum of actionThis section has been translated automatically.

Branhamella catarrhalis, Nocardia spp., Mycobacterium avium, fortuitum and tuberculosis.

IndicationThis section has been translated automatically.

Septic infections in the urogenital area, severe infections of the lower respiratory tract, peritonitis, sepsis, bone, joint and soft tissue infections, burns, infections with atypical mycobacteria, especially in immunocompromised patients.

Dosage and method of useThis section has been translated automatically.

10-15 mg/kg bw/day i.v. distributed over 2-3 single doses (increase of the daily dose up to 22 mg/kg bw/day for vital indications).

Notice! A GD of 15 g amikacin including previously applied aminoglycosides should not be exceeded!

PreparationsThis section has been translated automatically.

Amikacin, Biklin

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer